Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Titration of Lacosamide in Focal Epilepsy
NCT03607851Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lacosamide in focal epilepsy (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of adverse events at 8 weeks. Started Aug 2018; status: completed.
02
Drugs
lacosamide
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT03607851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03607851.